Selank-amide
Selank-amide is a cognitive enhancement peptide that has gained attention for its potential health benefits. Research suggests it may help with various health outcomes.
Mechanisms of Action
Selank-amide is listed as a cognitive enhancement peptide with mechanisms including GHRH agonist, Ghrelin mimetic. Its current research status is Approved, and its Australian access status is Research Only.
Potential Benefits
The potential benefits listed for Selank-amide include anxiety reduction, cognitive enhancement. These are educational research summaries, not treatment claims or personal medical advice.
- anxiety reduction
- cognitive enhancement
Potential Side Effects
Possible side effects reported for Selank-amide include drowsiness. Safety, suitability, and medication interactions should be assessed by a qualified clinician.
Frequently Asked Questions
What is Selank-amide?
Selank-amide is a cognitive enhancement peptide listed with mechanisms including GHRH agonist, Ghrelin mimetic. Current research status: Approved.
Is Selank-amide legal in Australia?
In Australia, Selank-amide is classified as: Research Only. Access and use should be checked against current Australian regulation and clinician guidance.
What dosage information is listed for Selank-amide?
The dosage field in this educational database lists 442mcg daily. This is not a dosing recommendation; suitability and dosing require medical supervision.
Sources and clinical context
Varney Health frames peptide pages as educational research guides, not prescribing advice. Current Australian access, safety, and suitability should be checked with an AHPRA-registered clinician.
Important Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional before starting any peptide therapy. Peptides may have different effects on different individuals and may interact with medications.